Girentuximab is a monoclonal chimeric (mouse/human) antibody directed against carbonic anhydrase IX, an antigen expressed in 95% of clear cell renal cell carcinomas (RCC).
货号（Catalog No.）
CSD00224
通用名INN
Girentuximab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Girentuximab is a monoclonal chimeric (mouse/human) antibody directed against carbonic anhydrase IX, an antigen expressed in 95% of clear cell renal cell carcinomas (RCC).
别名(Alternative names)
WX-G250,cG250
靶点;物种(Specificity target name;species)
CA9[Homo sapiens]
种类(Species)
Chimeric
受体鉴定(Receptor identification)
IgG1-kappa
化学信息
CAS
916138-87-9
存储条件(Storage)
store at -80°C
Note
For research use only. Not suitable for clinical or therapeutic use.
...
产品展厅
